Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A Final results from the ASPIRE extension study
dc.citation.doi | 10.1111/HAE.13953 | |
dc.citation.epage | 502 | |
dc.citation.spage | 494 | |
dc.contributor.author | Beatrice Nolan | |
dc.contributor.author | Johnny Mahlangu | |
dc.contributor.author | Ingrid Pabinger | |
dc.contributor.author | Guy Young | |
dc.contributor.author | Barbara Konkle | |
dc.contributor.author | A Et Al | |
dc.date.accessioned | 2023-10-06T12:02:43Z | |
dc.date.available | 2023-10-06T12:02:43Z | |
dc.identifier.citation | WOS | |
dc.identifier.issn | 1351-8216 | |
dc.identifier.uri | https://hdl.handle.net/10539/36425 | |
dc.journal.title | HAEMOPHILIA | |
dc.journal.volume | 26 | |
dc.title | Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A Final results from the ASPIRE extension study |
Files
Original bundle
1 - 1 of 1